This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1996 Jul;28(1):283.

doi: 10.1016/0735-1097(96)87143-9.

Effect of smoking status on response to thrombolytic therapy

D Zahger, P K Shah

PMID: 8752826
DOI: 10.1016/0735-1097(96)87143-9

Free article

Comment

Effect of smoking status on response to thrombolytic therapy

D Zahger et al. J Am Coll Cardiol. 1996 Jul.

Free article

. 1996 Jul;28(1):283.

doi: 10.1016/0735-1097(96)87143-9.

Authors

D Zahger, P K Shah

PMID: 8752826
DOI: 10.1016/0735-1097(96)87143-9

No abstract available

PubMed Disclaimer

Comment on

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
Barbash GI, Reiner J, White HD, Wilcox RG, Armstrong PW, Sadowski Z, Morris D, Aylward P, Woodlief LH, Topol EJ. Barbash GI, et al. J Am Coll Cardiol. 1995 Nov 1;26(5):1222-9. doi: 10.1016/0735-1097(95)00299-5. J Am Coll Cardiol. 1995. PMID: 7594035 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information